Clinical Trial Update: Multi-Tracer PET Prediction and Assessment of Response to Gemcitabine in Pancreatic Cancer Patients [NA]

View source ↗

Summary

Completed clinical trial investigating multi-tracer PET to predict and assess gemcitabine response in pancreatic cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: University of Utah | Conditions: Pancreatic Cancer | NA | Status: COMPLETED | Results posted: 2018-03-08